theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Gynecologic Oncology

Bladder Cancer   

Questions discussed in this category


Do you routinely use mannitol to prevent cisplatin-induced nephrotoxicity?
If so, do you use it for all patients or only cisplatin doses >= 70 mg/m2? What dose of mannitol do you use?
4 Answers available
12404


Papers discussed in this category


Cancer chemotherapy and pharmacology, 2003-07
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.

J Oncol Pharm Pract, 2009 Sep 16
A comparison of the rates of cisplatin (cDDP)--induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure.

Cancer Treat Rep,
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.

Ann Pharmacother, 2012 Jan 31
The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.

Related Topics in Gynecologic Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.